AZD 2171; ZD 2171
288383-20-0
450.5
C25H27FN4O3
DMF, DMSO, Ethanol
-20°C
Cediranib is a tyrosine kinase inhibitor that targets vascular endothelial growth factor receptors (VEGFR) 1, 2, and 3, c-KIT, and platelet-derived growth factor receptors. Studies show cediranib to be generally well tolerated as monotherapy at doses of 45 mg/d or less.
0.1 lbs
Research or further manufacturing use only, not for food or drug use.
